Andrew L Pecora

This inventor holds 18 USPTO granted patents and 7 published patent applications, plus 5 CIPO patents and 8 EPO patents, primarily in Clinical Outcomes Analysis. Top assignees: Amorcyte, Inc., Cota, Inc., Hackensack University Medical Center. Active years: 2010-2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Andrew L Pecora. Retrieved from https://idiyas.com/inventor/andrew-l-pecora

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

USPTO Granted Patents = 18 (Patent Applications = 7)

% Patents Active = 83.3

CIPO Patents = 5 (Patent Applications = 4)

EPO Patents = 8 (Patent Applications = 11)

Average Co-Inventor Count = 1.5

ph-index = 10

Forward Citations = 150(Granted Patents)

Location History:

Ridgewood, NJ (US) (2010 - 2012)
Wyckoff, NJ (US) (2013 - 2017)
Hackensack, NJ (US) (2019)
Wycoff, NJ (US) (2016 - 2020)
Rumson, NJ (US) (2017 - 2021)

Company Filing History:

Hackensack University Medical Center

patents

4. 1 out of 834,708

Other

patents

Years Active: 2010-2026

Loading Chart...

Areas of Expertise:

Clinical Outcome Tracking

Ovarian Cancer Biomarkers

Skin Cancer Treatment

Radiation Therapy

Myocardial Injury

Vascular Injury Repair

CNA-Guided Care

Cost of Care

18 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 12793838 - Clinical outcome tracking and analysis systems and methods employing provisional nodal addresses relevant to treatment and refined nodal addresses relevant to prognosis-related expected outcome and risk assessment (2026-11-10),

2. 10902953 - Clinical outcome tracking and analysis (2021-01-26),

3. 10662478 - Serine proteases as biomarkers for ovarian cancer (2020-05-26),

4. 10195466 - Method for treating skin cancer using radiation therapy (2019-02-05),

5. 9734291 - CNA-guided care for improving clinical outcomes and decreasing total cost of care (2017-08-15),

6. 9734289 - Clinical outcome tracking and analysis (2017-08-15),

7. 9734288 - Clinical outcome tracking and analysis (2017-08-15),

8. 9646135 - Clinical outcome tracking and analysis (2017-05-09),

9. 9534202 - Compositions and methods for treating progressive myocardial injury due to a vascular insufficiency (2017-01-03),

10. 9533010 - Compositions and methods for treating progressive myocardial injury due to a vascular insufficiency (2017-01-03),

11. 9378531 - Clinical outcome tracking and analysis (2016-06-28),

12. 9034316 - Infarct area perfusion-improving compositions and methods of vascular injury repair (2015-05-19),

13. 8709403 - Compositions and methods of vascular injury repair (2014-04-29),

14. 8637005 - Compositions and methods of vascular injury repair (2014-01-28),

15. 8425899 - Compositions and methods for treating progressive myocardial injury due to a vascular insufficiency (2013-04-23),

Title: The Innovative Contributions of Andrew L. Pecora

Introduction

Andrew L. Pecora is a notable inventor based in Wyckoff, New Jersey, with a remarkable portfolio of 17 patents. His work primarily focuses on advancements in clinical outcomes and cancer diagnostics, showcasing his commitment to improving healthcare through innovative solutions.

Latest Patents

One of Pecora's latest patents is centered around clinical outcome tracking and analysis. This invention provides a comprehensive system and method for tracking clinical outcomes, which includes sorting patient data based on various parameters such as age, ethnicity, and medical history. The system aims to enhance treatment effectiveness and reduce inefficiencies in healthcare delivery. Another significant patent involves the use of serine proteases as biomarkers for ovarian cancer. This invention outlines methods for detecting and diagnosing low-grade and stage I ovarian cancer by analyzing serum and ovarian tissue samples, thereby facilitating early intervention and treatment.

Career Highlights

Throughout his career, Pecora has made significant contributions to the medical field, particularly in the areas of clinical research and patient care. He has worked with various companies, including Amorcyte, Inc. and Cota, Inc., where he has applied his expertise to develop innovative healthcare solutions.

Collaborations

Pecora has collaborated with esteemed colleagues such as Robert A. Preti and K. Stephen Suh, further enhancing his contributions to the field of medicine and innovation.

Conclusion

Andrew L. Pecora's inventive spirit and dedication to healthcare innovation have led to significant advancements in clinical outcome tracking and cancer diagnostics. His work continues to impact the medical community positively, paving the way for improved patient care and treatment methodologies.

Profile summary based on public USPTO records.